R. Laduane Clifton - Net Worth and Insider Trading
R. Laduane Clifton Net Worth
The estimated net worth of R. Laduane Clifton is at least $175,707 dollars as of 2024-12-28. R. Laduane Clifton is the CFO & Treasurer of Zevra Therapeutics Inc and owns about 18,469 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $154,955. R. Laduane Clifton is also the Chief Accounting Officer of LGL Group Inc and owns about 3,606 shares of LGL Group Inc (LGL) stock worth over $20,753. Details can be seen in R. Laduane Clifton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R. Laduane Clifton has not made any transactions after 2024-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of R. Laduane Clifton
R. Laduane Clifton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R. Laduane Clifton owns 2 companies in total, including Zevra Therapeutics Inc (ZVRA) , and LGL Group Inc (LGL) .
Click here to see the complete history of R. Laduane Clifton’s form 4 insider trades.
Insider Ownership Summary of R. Laduane Clifton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2024-07-17 | VP Fin & Corp Controller |
| LGL | LGL Group Inc | 2011-08-31 | Chief Accounting Officer |
R. Laduane Clifton Latest Holdings Summary
R. Laduane Clifton currently owns a total of 2 stocks. Among these stocks, R. Laduane Clifton owns 18,469 shares of Zevra Therapeutics Inc (ZVRA) as of July 17, 2024, with a value of $154,955 and a weighting of 88.19%. R. Laduane Clifton also owns 3,606 shares of LGL Group Inc (LGL) as of August 31, 2011, with a value of $20,753 and a weighting of 11.81%.
Latest Holdings of R. Laduane Clifton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZVRA | Zevra Therapeutics Inc | 2024-07-17 | 18,469 | 8.39 | 154,955 |
| LGL | LGL Group Inc | 2011-08-31 | 3,606 | 5.76 | 20,753 |
Holding Weightings of R. Laduane Clifton
R. Laduane Clifton Form 4 Trading Tracker
According to the SEC Form 4 filings, R. Laduane Clifton has made a total of 18 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 18 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 2,000 shares on July 17, 2024, which cost R. Laduane Clifton around $13,540.
According to the SEC Form 4 filings, R. Laduane Clifton has made a total of 0 transactions in LGL Group Inc (LGL) over the past 5 years. The most-recent trade in LGL Group Inc is the acquisition of 51 shares on August 31, 2011, which cost R. Laduane Clifton around $393.
Insider Trading History of R. Laduane Clifton
- 1
R. Laduane Clifton Trading Performance
GuruFocus tracks the stock performance after each of R. Laduane Clifton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R. Laduane Clifton is 10.83%. GuruFocus also compares R. Laduane Clifton's trading performance to market benchmark return within the same time period. The performance of stocks bought by R. Laduane Clifton within 3 months outperforms 11 times out of 30 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R. Laduane Clifton's insider trading performs compared to the benchmark.
Performance of R. Laduane Clifton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.41 | | | | | |
| Relative Return to S&P 500(%) | 1.58 | | | | | |
R. Laduane Clifton Ownership Network
R. Laduane Clifton Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
R. Laduane Clifton is the VP Fin & Corp Controller of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include director & President and CEO Neil F. Mcfarlane , CCO & EVP & Bus. Development Joshua Schafer , and VP & Corporate Controller Timothy J. Sangiovanni .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, R. Laduane Clifton made 2 insider transaction in Zevra Therapeutics Inc (ZVRA) with a net purchase of 3,000. Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 20,000 shares made by Thomas Anderson , a net purchase of 20,000 shares made by John B Bode , and a net purchase of 500 shares made by Joshua Schafer .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 44,000 shares were bought by its insiders, resulting in a net purchase of 44,000 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
R. Laduane Clifton Mailing Address
Above is the net worth, insider trading, and ownership report for R. Laduane Clifton. You might contact R. Laduane Clifton via mailing address: C/o Kempharm, Inc., 1170 Celebration Blvd., #103, Celebration Fl 34747.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
